NCT00822744 - An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients | Biotech Hunter

Enrollment

527

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions

Major Depressive Disorder

Interventions

DRUG

SSR411298

"Form: capsule~Route: oral administration with food"

DRUG

Escitalopram

"Form: capsule (commercial escitalopram tablets were encapsulated within opaque capsules)~Route: oral administration with food"

DRUG

Placebo (for SSR411298)

"Form: capsule~Route: oral administration with food"

Trial Locations (7)

Sanofi-Aventis Administrative Office, Santiago

Sanofi-Aventis Administrative Office, México

Sanofi-Aventis Administrative Office, Bucharest

Sanofi-Aventis Administrative Office, Moscow

Sanofi-Aventis Administrative Office, Brastislava

Sanofi-Aventis Administrative Office, Midrand

Sanofi-Aventis Administrative Office, Kiev